Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats

Journal of the Science of Food and Agriculture

Volumn 95, Issue 15, 2015, Pages 3177-3182

  Naidu, Parim Brahma ^a   Ponmurugan, Ponnusamy ^b   Begum, Mustapha Sabana ^c   Mohan, Karthick ^d   Meriga, Balaji ^a   Ravindarnaik, Ramavat ^e   Saravanan, Ganapathy ^f  

^a SRI VENKATESWARA UNIVERSITY   (India)

^b K S RANGASAMY COLLEGE OF TECHNOLOGY   (India)

^c MUTHAYAMMAL COLLEGE OF ARTS AND SCIENCE   (India)

^d ST JOSEPH S COLLEGE   (India)

^e NATIONAL INSTITUTE OF NUTRITION   (India)

^f K S RANGASAMY COLLEGE OF ARTS AND SCIENCE AUTONOMOUS   (India)

Author keywords

Diabetes; Diosgenin; Lipids; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; DIOSGENIN; FAT INTAKE; GLUCOSE BLOOD LEVEL; INSULIN; LIPID; PLANT EXTRACT;

ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; DYSLIPIDEMIAS; FAT INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MALE; METABOLISM; PHYTOTHERAPY; TRIGONELLA; WEIGHT GAIN; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DIETARY FATS; DIOSGENIN; DYSLIPIDEMIAS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS, WISTAR; TRIGONELLA; WEIGHT GAIN;

EID: 84946471442     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.7057     Document Type: Article

References (49)

1. Kumar P and Kumar A, Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206:38-46 (2010).
2. Shaw JE, Sicree RA and Zimmet PZ, Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14 (2010).
3. Wild S, Roglic G, Green A, Sicree R and King H, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (2004).
4. Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR et al., Urban rural differences in prevalence of selfreported diabetes in India - the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract 80:159-168 (2008).
5. Xu L, Xie X, Wang S, Wang Y and Jonas JB, Prevalence of diabetes mellitus in China. Exp Clin Endocrinol Diabetes 116:69-70 (2008).
6. rd edition, ed. by Gan D. International Diabetes Federation, Belgium, pp. 15-103 (2006).
7. Mehta SR, Kashyap AS and Das S, Diabetes mellitus in India: The modern scourge. Med J Armed Forces India 65:50-54 (2009).
8. Colagiuri S, Diabesity: Therapeutic options. Diabetes Obesity Metab 12:463-473 (2010).
9. Stadler K, Jenei V, von Bölcsházy G, Somogyi A and Jakus J, Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Méd 35:1240-1251 (2003).
10. Reasner CA, Reducing cardiovascular complications of diabetes by targeting multiple risk factors. J Cardiovasc Pharmacol 52:136-44 (2008).
11. Nagappa AN, Thakurdesai PA, Rao NV and Singh J, Antidiabetic activity of Termanalia catappa Linn. fruits. J Ethnopharamacol 88:45-50 (2003).
12. Veerapur VP, Prabhakar KR, Thippeswamy BS, Bansal P, Srinivasan KK and Unnikrishnan MK, Antidiabetic effect of Dodonaea viscosa (L). Lacq. aerial parts in high fructose-fed insulin resistant rats: A mechanism based study. Indian J Exp Biol 48:800-810 (2010).
13. Saravanan G and Ponmurugan P, Ameliorative potential of S-allylcysteine: Effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes. Exp Toxicol Pathol 64:639-644 (2012).
14. Pushparaj P, Tan CH and Tan BKH, Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol 72:69-76 (2000).
15. Chen H, Ward MH and Graubard BI, Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 75:137-144 (2002).
16. Superko HR, Drug therapy and the prevention of atherosclerosis in humans. Am J Cardiol 64:31G-38G (1989).
17. Ribes Y, Sauvaire CD, Costa JC and Loubatieres-Mariani MM, Antidiabetic effects of subtractions from fenugreek seeds in diabetic dogs. Proc Soc Exp Biol Med 182:159-166 (1986).
18. Swanston-Flatt SK, Day C and Flatt PR, Glycemic effect of traditional European plants treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 10:69-73 (1989).
19. Sharma RD, Sarkar A and Hazra DK, Use of fenugreek seeds powder in the management of noninsulin dependent diabetes mellitus. Nutr Res 16:1331-1339 (1996).
20. Pari L, Monisha P and Jalaludeen AM, Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats. Eur J Pharmacol 691:143-150 (2012).
21. Mohammad I and Mohammad Y, Clinical evaluation of antidiabetic activity of Trigonella seeds and Aegle marmelos leaves. World Appl Sci J 7:1231-1234 (2009).
22. Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P, Combination of high fat diet-fed and low-dose streptozotocin-treated rat: A model for type-2 diabetes and pharmacological screening. Pharmacol Res 52:313-320 (2005).
23. Saravanan G, Ponmurugan P, Deepa MA and Senthilkumar B, Modulatory effects of diosgenin on attenuating the key enzymes activities of carbohydrate metabolism and glycogen content in streptozotocin induced diabetic rats. Can J Diabetes 38:409-414 (2014).
24. Pulido N, Suarez A and Casanova B, Glyclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle. Metabolism 46:10-13 (1997).
25. Folch C, Lees M and Solane SGH, A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509 (1957).
26. Zlatkis A, Zak B and Boyle GJ, A simple method for determination of serum cholesterol. J Lab Clin Med 41:486-492 (1953).
27. Fossati P and Lorenzo P, Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080 (1982).
28. Falholt K, Falholt W and Lund B, An easy colorimetric method for routine determination of free fatty acids in plasma. Clin Chim Acta 46:105-111 (1973).
29. Zilversmit DB and Davis AK, Micro determination of phospholipids by TCA precipitation. J Lab Clin Med 35:155-159 (1950).
30. Zhang XF and Tan BK, Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol 27:358-363 (2000).
31. Arulselvan P and Subramanian SP, Beneficial effects of Murraya koenigii leaves on of pancreatic β-cells in experimental diabetes in rats. Chem Biol Int 165:155-164 (2007).
32. Chauhan UPS, Jagi CB and Singh VN, Incorporation of 32Pi into plasma phosphatidylcholine of diabetic rats. Indian J Nuclear Med 2:92-98 (1987).
33. Shi Y and Burn P, Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Dis 3:695-710 (2004).
34. Saravanan G, Ponmurugan P, Deepa MA and Senthilkumar B, Anti-obesity action of gingerol: Effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J Sci Food Agric 94:2972-2977 (2014).
35. Saravanan R and Pari L, Succinic acid monoethyl ester, a novel insulinotropic agent: Effect on lipid composition and lipid peroxidation in streptozotocin-nicotinamide induced type 2 diabetic rats. Mol Cell Biochem 296:165-176 (2007).
36. Sena CM, Nunes E and Louro T, Effects of a-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br J Pharmacol 153:894-906 (2008).
37. Satheesh AM and Pari L, Effect of pterostilbene on lipids and lipid profiles in streptozotocin-nicotinamide induced type 2 diabetes mellitus. J Appl Biomed 6:31-37 (2007).
38. Saravanan G and Ponmurugan P, Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats. Chem Biol Int 189:100-106 (2011).
39. Saravanan R and Pari L, Effect of a novel insulinotropic agent, succinic acid monoethyl ester, on lipids and lipoproteins levels in rats with streptozotocin-nicotinamide induced type 2 diabetes. J Biosci 31:581-587 (2006).
40. Kudchodkar BJ, Lee MJ, Lee SM, Di Marco NM and Lacko AG, Effect of dietary protein on cholesterol homeostasis in diabetic rats. J Lipid Res 29:1272-1287 (1988).
41. Colca JR, Dailey CF, Palazuk BJ, Hillman RM, Dinh DM, Melchior GW et al., Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol fed rats. Diabetes 40:1669-1674 (1991).
42. Zhi Liu, Wei Li and Xiang Li, Antidiabetic effects of malonylginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. J Ethnopharmacol 145:233-240 (2013).
43. Zhang L, Keung W, Samokhvalov V, Wang W and Lopaschuk G, Role of fatty acid uptake and fatty acid β-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta 1801:1-22 (2010).
44. Furler SM, Poynten AM, Kriketos AD, Lowy AJ, Ellis BA et al., Independent influences of central fat and skeletal muscle lipids on insulin sensitivity. Obes Res 9:535-543 (2001).
45. Kuwahara Y, Yanagishita T, Konno N and Katagiri T, Changes in microsomal membrane phospholipids and fatty acids and in activities of membrane-bound enzymes in diabetic rat heart. Basic Res Cardiol 92:214-222 (1997).
46. Yagi K, Lipid peroxides and human diseases. Chem Phys Lipids 45:337-351 (1987).
47. Christe ME and Rodgers RL, Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat. Hypertension 25:235-241 (1995).
48. Al-Numair KS, Chandramohan G and Kamalakkannan N, Effect of camel milk on the activities of ATPases in normal and streptozotocin-diabetic rats. Polish J Food Nutr Sci 60:375-380 (2010).
49. Jagadeesan AJ, Langeswaran K and Gowtham Kumar S, Chemopreventive potential of diosgenin on modulating glycoproteins, TCA cycle enzymes, carbohydrate metabolizing enzymes and biotransformation enzymes against N-methyl-N-nitrosourea induced mammary carcinogenesis. Int J Pharm Pharm Sci 5:575-582 (2013).